Valeant Pharmaceuticals International Inc. on Tuesday said its improved offer for Botox maker Allergan Inc. won't be an all-cash deal.
from WSJ.com: US Business http://ift.tt/1lZjf7n
via IFTTT
from WSJ.com: US Business http://ift.tt/1lZjf7n
via IFTTT
No comments:
Post a Comment